Dzhivhuho G, Jackson P, Honeycutt E, da Silva Mesquita F, Huang J, Hammarskjold M
bioRxiv. 2025; .
PMID: 39829859
PMC: 11741256.
DOI: 10.1101/2025.01.06.631466.
Jackson P, Holsey J, Turse L, Hammarskjold M, Rekosh D
Open Forum Infect Dis. 2023; 10(10):ofad486.
PMID: 37854107
PMC: 10580148.
DOI: 10.1093/ofid/ofad486.
Li J, Zhang X, Bai B, Zhang M, Ma W, Lin Y
J Virol. 2022; 96(24):e0121022.
PMID: 36448796
PMC: 9769392.
DOI: 10.1128/jvi.01210-22.
Duan Y, Wang X, Sun K, Lin Y, Wang X, Chen K
J Virol. 2022; 96(20):e0054922.
PMID: 36197105
PMC: 9599250.
DOI: 10.1128/jvi.00549-22.
Sherpa C, Jackson P, Gray L, Anastos K, Le Grice S, Hammarskjold M
J Virol. 2019; 93(11).
PMID: 30867301
PMC: 6532081.
DOI: 10.1128/JVI.02102-18.
Rev variation during persistent lentivirus infection.
Carpenter S, Chen W, Dorman K
Viruses. 2011; 3(1):1-11.
PMID: 21994723
PMC: 3187595.
DOI: 10.3390/v3010001.
Molecular detection, epidemiology, and genetic characterization of novel European field isolates of equine infectious anemia virus.
Cappelli K, Capomaccio S, Cook F, Felicetti M, Marenzoni M, Coppola G
J Clin Microbiol. 2010; 49(1):27-33.
PMID: 21084503
PMC: 3020406.
DOI: 10.1128/JCM.01311-10.
Genomic analysis of an effective lentiviral vaccine-attenuated equine infectious anemia virus vaccine EIAV FDDV13.
Qi X, Wang X, Wang S, Lin Y, Jiang C, Ma J
Virus Genes. 2010; 41(1):86-98.
PMID: 20526660
DOI: 10.1007/s11262-010-0491-6.
Mapping of the functional boundaries and secondary structure of the mouse mammary tumor virus Rem-responsive element.
Mertz J, Chadee A, Byun H, Russell R, Dudley J
J Biol Chem. 2009; 284(38):25642-52.
PMID: 19632991
PMC: 2757966.
DOI: 10.1074/jbc.M109.012476.
Structural model of the Rev regulatory protein from equine infectious anemia virus.
Ihm Y, Sparks W, Lee J, Cao H, Carpenter S, Wang C
PLoS One. 2009; 4(1):e4178.
PMID: 19137065
PMC: 2613556.
DOI: 10.1371/journal.pone.0004178.
Analysis of the EIAV Rev-responsive element (RRE) reveals a conserved RNA motif required for high affinity Rev binding in both HIV-1 and EIAV.
Lee J, Culver G, Carpenter S, Dobbs D
PLoS One. 2008; 3(6):e2272.
PMID: 18523581
PMC: 2386976.
DOI: 10.1371/journal.pone.0002272.
Naturally arising point mutations in non-essential domains of equine infectious anemia virus Rev alter Rev-dependent nuclear-export activity.
Sparks W, Dorman K, Liu S, Carpenter S
J Gen Virol. 2008; 89(Pt 4):1043-1048.
PMID: 18343848
PMC: 4425282.
DOI: 10.1099/vir.0.83195-0.
Evolution of the long terminal repeat and accessory genes of feline immunodeficiency virus genomes from naturally infected cougars.
Poss M, Ross H
Virology. 2007; 370(1):55-62.
PMID: 17904608
PMC: 2215318.
DOI: 10.1016/j.virol.2007.08.024.
Cloning and large-scale expansion of epitope-specific equine cytotoxic T lymphocytes using an anti-equine CD3 monoclonal antibody and human recombinant IL-2.
Mealey R, Littke M, Leib S, Davis W, McGuire T
Vet Immunol Immunopathol. 2007; 118(1-2):121-8.
PMID: 17498813
PMC: 2002571.
DOI: 10.1016/j.vetimm.2007.04.001.
Identifying interaction sites in "recalcitrant" proteins: predicted protein and RNA binding sites in rev proteins of HIV-1 and EIAV agree with experimental data.
Terribilini M, Lee J, Yan C, Jernigan R, Carpenter S, Honavar V
Pac Symp Biocomput. 2006; :415-26.
PMID: 17094257
PMC: 2553683.
Characterization of functional domains of equine infectious anemia virus Rev suggests a bipartite RNA-binding domain.
Lee J, Murphy S, Belshan M, Sparks W, Wannemuehler Y, Liu S
J Virol. 2006; 80(8):3844-52.
PMID: 16571801
PMC: 1440447.
DOI: 10.1128/JVI.80.8.3844-3852.2006.
Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism.
Maury W, Thompson R, Jones Q, Bradley S, Denke T, Baccam P
J Virol. 2005; 79(9):5653-64.
PMID: 15827180
PMC: 1082720.
DOI: 10.1128/JVI.79.9.5653-5664.2005.
Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus.
Payne S, Pei X, Jia B, Fagerness A, Fuller F
J Virol. 2004; 78(5):2478-85.
PMID: 14963146
PMC: 369206.
DOI: 10.1128/jvi.78.5.2478-2485.2004.
Subpopulations of equine infectious anemia virus Rev coexist in vivo and differ in phenotype.
Baccam P, Thompson R, Li Y, Sparks W, Belshan M, Dorman K
J Virol. 2003; 77(22):12122-31.
PMID: 14581549
PMC: 254257.
DOI: 10.1128/jvi.77.22.12122-12131.2003.
Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus.
Mealey R, Zhang B, Leib S, Littke M, McGuire T
Virology. 2003; 313(2):537-52.
PMID: 12954220
PMC: 3342690.
DOI: 10.1016/s0042-6822(03)00344-1.